FDA Inspection
Hospira IncHospira Inc – FDA Inspection, Jun 7, 2024
Record Details
This FDA Inspection record concerns Hospira Inc, with an inspection on June 7, 2024, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 251b750d-e7dd-4072-b32a-338d73b69de8
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1241064
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of Hospira Inc
9| Date | Classification | Office | Project area |
|---|---|---|---|
| August 22, 2025 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 27, 2020 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 13, 2015 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| December 9, 2014 | NAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| September 9, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Hospira Inc
- FDA Inspection 1278254 - 2025-08-22
- FDA Inspection 1121881 - 2020-02-27
- FDA Inspection 919379 - 2015-04-13
- FDA Inspection 906256 - 2014-12-09
- FDA Inspection 846706 - 2013-09-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.